Tentative US approval for Merck’s diabetes therapy
admin 21st July 2017 Uncategorised 0The US Food and Drug Administration has given a tentative green light to Merck & Co’s follow-on biologic basal insulin Lusduna Nexvue.
More: Tentative US approval for Merck’s diabetes therapy
Source: News